“Revised LI-RADS Category 5 Shows Higher Sensitivity in HCC Diagnosis than LI-RADS v2018 Category 5”

https://pubmed.ncbi.nlm.nih.gov/38112549

The revised LI-RADS (rLI-RADS) category 5 (rLR-5) has higher sensitivity for hepatocellular carcinoma (HCC) diagnosis compared to LI-RADS v2018 category 5 (LR-5), while maintaining similar positive predictive value in a multicenter data set.